Hinge Health (HNGE) president relinquishes 831 shares to cover RSU taxes

Rhea-AI Filing Summary

Hinge Health, Inc. President James Pursley reported a routine tax-related share disposition. On this Form 4, 831 shares of Class A Common Stock were withheld and cancelled at a value of $38.56 per share to cover federal and state tax withholding from the vesting of restricted stock units. After this transaction, Pursley directly holds 731,273 shares of Hinge Health Class A Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pursley James

Role President

Type	Security	Shares	Price	Value
Tax Withholding	Class A Common Stock	831	$38.56	$32K

Holdings After Transaction: Class A Common Stock — 731,273 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 831 shares Withholding share value: $38.56 per share Shares held after transaction: 731,273 shares

3 metrics

Shares withheld for taxes 831 shares Class A Common Stock disposed for tax withholding

Withholding share value $38.56 per share Value used for 831-share tax-withholding disposition

Shares held after transaction 731,273 shares Direct Class A Common Stock holdings after withholding

Key Terms

restricted stock units, Section 16b-3(e), tax withholding obligations

3 terms

restricted stock units financial

"resulting from the vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Section 16b-3(e) regulatory

"Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price"

tax withholding obligations financial

"to pay federal and state tax withholding obligations of the Reporting Person"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pursley James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/01/2026		F(1)		831	D	$38.56	731,273	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

	/s/ James Budge, Attorney-in-Fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Hinge Health (HNGE) report for President James Pursley?

Hinge Health reported that President James Pursley had 831 Class A shares withheld and cancelled to cover tax obligations from restricted stock unit vesting, rather than executing an open-market sale. This is a routine compensation-related tax-withholding transaction disclosed on Form 4.

How many Hinge Health (HNGE) shares were involved in James Pursley’s Form 4 filing?

The filing shows 831 shares of Hinge Health Class A Common Stock were disposed of through withholding and cancellation. These shares were used to satisfy federal and state tax withholding obligations tied to the vesting of restricted stock units issued under a compensation plan.

At what price were the withheld Hinge Health (HNGE) shares valued in the Form 4?

The 831 withheld shares were valued at $38.56 per share. This value is used in the Form 4 to reflect the price at which shares were effectively surrendered to the issuer to cover the reporting person’s tax liability from restricted stock unit vesting.

How many Hinge Health (HNGE) shares does James Pursley hold after this transaction?

After the tax-withholding disposition, President James Pursley directly holds 731,273 shares of Hinge Health Class A Common Stock. This post-transaction share balance is reported in the Form 4 as the total number of shares beneficially owned following the withholding and cancellation event.

Was James Pursley’s Hinge Health (HNGE) transaction an open-market sale?

No. The Form 4 and footnote state the transaction was an exempt event under Section 16b-3(e), where 831 shares were relinquished and cancelled by the issuer solely to pay tax withholding obligations arising from the vesting of restricted stock units, not a discretionary market sale.